JAK KINASE INHIBITORS AND SKIN CANCER
Jalles et al (starts at 5:29). Skin cancers under Janus kinase inhibitors: A World Health Organization drug safety database analysis. Therapie. 2022 May 7;S0040-5957(22)00092-0.
 
ISOTRETINOIN LAB MONITORING
Xia E et al (starts at 13:36). Isotretinoin Laboratory Monitoring in Acne Treatment: A Delphi Consensus Study. JAMA Dermatol. 2022 Jun 15.
 
ISOTRETINOIN & SURGERY
Davis and Perkins (starts at 18:28). Oral isotretinoin (Roaccutane) use during incisional surgery: safe or risky? Case Reports Plast Surg Hand Surg. 2022 May 13;9(1):131-134.
Spring L et al (starts at 20:17). Isotretinoin and Timing of Procedural Interventions: A Systematic Review With Consensus Recommendations. JAMA Dermatol. 2017 Aug 1;153(8):802-809.
Mysore V et al. Standard Guidelines of Care: Performing Procedures in Patients on or Recently Administered with Isotretinoin J Cutan Aesthet Surg. 2017 Oct-Dec; 10(4): 186–194.
 
CONGENITAL TRIANGULAR ALOPECIA
Shimrada K et al (starts at 23:57). Atypical Localization of Congenital Triangular Alopecia Associated with Down's Syndrome. Indian J Dermatol. 2022 Jan-Feb; 67(1): 94
Starace M et al (starts at 25:40). Atypical Presentation of Congenital Triangular Alopecia: A Case Series in Italy. Dermatol Pract Concept Oct 2020.
 
HYDROXYCHLOROQUINE DOSING
Chen R et al (ssarts at 30:00). Impact of an Electronic Decision Support Tool to Improve Ophthalmic Safety in Hydroxychloroquine Prescribing Practices Ophthalmic Surg Lasers Imaging Retina. 2022 Jun;53(6):310-316.
Melles & Marmor (starts at 31:24). The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine Therapy. JAMA Ophthalmol. 2014;132(12):1453–1460.